All News

LTOT opioid therapy declines, but gabapentinoid coprescribing rises—impact on chronic pain management, safety, and prescriptions.

Pharmacists can improve statin adherence and refine triglyceride management by leveraging patient-centered counseling, adherence strategies, and updated guideline recommendations prioritizing statins and targeted adjunctive therapies.

There is a growing need to integrate pharmacists into sports medicine teams, where their expertise in medication safety, chronic disease management, and supplements can significantly enhance athlete care and performance.

This interview highlights the importance of integrating holistic health, lifestyle coaching, and medication management to create more effective, patient-centered care.

Pharmacists play a critical role in bridging athlete performance and safety, emphasizing foundational health habits, addressing supplement misconceptions, and supporting mental health through frequent, trusted patient interactions.

Travis Tygart, JD, discusses the growing risks of supplements and the critical need for education and vigilance to protect athletes and uphold clean sport.

Nilhan Uzman, MS, BPharm, discusses how pharmacists elevate athlete care by guiding safe use of medicines and supplements, debunking “natural” myths, and strengthening clean sport teams.

ASCO guidelines reshape multiple myeloma care with quadruplet induction, earlier CAR T-cell therapy and bispecifics, and selective smoldering treatment.

Kyle Fischer, PharmD, explains navigating payer hurdles, supporting adherence, and improving coordination in ILD and PAH care.

A unified specialty pharmacy platform replaces fragmented tools, streamlines access, boosts reimbursement clarity, and supports advanced therapies.

Using PEPFAR-backed HIV treatment in Zambia as minerals leverage will risk resistance, deaths, and US global health leadership.

Amy Seung outlines her priorities for leading HOPA through evolving therapies, workforce challenges, and expanding pharmacy roles.

Direct-to-consumer offerings were a shot across the bow. Direct-to-employer offerings are a torpedo to the midship of the PBM business model.

Clinical pharmacists are uniquely positioned to deliver a continuation appropriateness measure that no existing quality framework produces.

This week's episode highlights new data on the newly approved oral GLP-1, orforglipron, the growing role of sports pharmacists, and FDA approval of a higher-dose regimen for spinal muscular atrophy.

Pharmacists reshape care, from maternal medication safety to sustainability, cutting waste and improving public health across communities.

Phase 3 trial data show that isatuximab quadruplet improves MRD negativity in transplant-eligible patients with multiple myeloma.

Jennifer Goldman, PharmD, highlights clinical trial data and practical strategies for pharmacists to support initiation, adherence, and adverse effect management with tirzepatide at the American Pharmacists Association Annual Meeting and Exposition.

Researchers shed new light on how zinc deficiency contributes to severe disease and death, pointing to a specific intracellular protein as a key mediator.

Pacritinib bridges high-risk myelofibrosis to allogeneic stem cell transplantation, preserving blood counts, shrinking spleen and symptoms, and enabling 95% of patients to undergo transplantation.

Air pollution exposure, particularly fine particulate matter and ozone, may worsen cardiac outcomes in patients with breast cancer receiving cardiotoxic therapies.

Pharmacist Kyle Fischer, PharmD, APh, explains how antifibrotic therapy, drug interactions, and pharmacist–physician collaboration guide ILD care.

Waters Corporation's Onclarity HPV Self-Collection Kit represents a significant advance in expanding access to cervical cancer screening outside the clinic.

Pharmacists play a critical and evolving role in sports medicine by optimizing medication use, guiding safe supplementation, and delivering personalized, prevention-focused care to support athlete performance and overall health.

Independent pharmacies are being squeezed on reimbursement while their data quietly fuels billion-dollar decisions. A new pharmacy data economy could flip that script.